Target Industry: Bioinformatics

What is it?

The bioinformatics industry is comprised of companies using various enabling technologies that facilitate the annotation, storage, analysis and search/retrieval of nucleic acid sequence, protein sequence and structural information.

The industry includes the integration of information on the sequences and structures of nucleic acids and proteins into databases such as EMBL, as well as methods to access, search, model and analyze this information.

What are some of the major trends in the industry?

* The worldwide value of the bioinformatics market is expected to increase from $1.02 billion in 2002 to $3.0 billion in 2010, at an average annual growth rate (AAGR) of 15.8%.

* The fastest growing bioinformatics market is expected to be analysis software and services. It is estimated to grow from $444.7 million in 2005 to $1.2 billion in 2010.

* Applications of bioinformatics in drug discovery and development is expected to reduce the annual cost of developing a new drug by 33%, and the time for drug discovery by 30%.

* Pharmaceutical companies are expected to increase their R&D expenditures in the future and a major portion of this spending is expected to go into bioinformatics.

Who are some of the key players?

*ACCELRYS
*AFFYMETRIX
*AGILENT TECHNOLOGIES
*AMERSHAM BIOSCIENCES
*CELERA
*COMPUGEN
*CURAGEN
*GENE LOGIC
*GEOSPIZA
*IBM LIFE SCIENCES
*INCYTE
*LION BIOSCIENCE AG
*SILICON GRAPHICS
*TRIPOS